By Yafo Life Sciences
December 26th, 2021 (Shanghai) — We are glad to announce that Hyunsun Park, the CBO, COO of PharmAbcine Inc., has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan13th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.
If you are interested in listening to the live event, please register at https://biotochina.org/register/
About PharmAbcine Inc.
PharmAbcine Inc. is a R&D based biotech company focusing on developing antibody therapeutics in oncology, ocular and vascular diseases by targeting angiogenesis or immuno-oncology area.
About ACCESS CHINA
ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/
Contact US
Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 